- Prostate Cancer news are updated once a hour
- We deliver news from more than 500 sources on prostate cancer
NewsAdvertisers: |
The Master's Touch... One came in 1966 at a tournament on the Cherry Hills course outside Denver. Solidly ahead entering the final round of the U.S. Open, Palmer saw his commanding lead whittled away by the relentless, ironically Palmer-like charge of Billy Casper, who ultimately edged Palmer for the title. That defeat is not lost on him to this day. “When you reflect on something like losing a seven-stroke lead, it’s difficult,” Palmer concedes. “But after having won the Open and then losing the Open, like I did then, I found out a lot more about life, friendships and what life was all about. It was extremely gratifying to know that winning a golf tournament such as the Open at that point in time wasn’t the only thing in the world that can be gratifying.” A large part of that gratification for Palmer continues to be giving his best effort to whatever he’s involved with. And, as... Specialists Offer Biased Treatment Advice for Prostate Cancer... Ramsey, M.D., Ph.D., of the Fred Hutchinson Cancer Research Center here, and colleagues. "Given the bias in treatment preference by specialty, it is likely there is discordance in which treatment options are provided to patients and the strength of individual recommendations associated with each option," Dr. Ramsey and colleagues wrote in a study published online today by the journal Cancer. Choosing the most appropriate treatment for localized Ramsey and colleagues reviewed 69 original peer-reviewed articles focused on the
The treatment strategies covered by the studies included watc... EDAP TMS SA to Support Prostate Cancer Awareness Week in the UK ...... In meeting this demand, Ablatherm-HIFU from EDAP offers efficacy rates at five years of follow up showing a 93 percent success rate by biopsy. Ten-year efficacy data will be shared in April at the European Association of Urology meeting to be held in Paris. Ablatherm-HIFU treatment also has significantly lower side effects such as incontinence and impotence, requires a single treatment consisting of two to three hours and allows the patient to resume a normal lifestyle in a matter of days.A 63-year old patient treated in September 2005 following a diagnosis based on his PSA screen stated: "I had a serious health problem, and I did not know about it until the PSA test results. I'm so pleased about my treatment experience. I went into the hospital, had the procedure at 2 pm, the catheter was removed the following day and I was then able to go home - walking out of the door. I was back to my normal life in just days rather than weeks with other treatment options my GP presented in our discussions."Since its formal UK launch at Guy's Hospital in December 2005, the number of sites having access to Ablatherm-HIFU has increased from three to today 14 throughout the U.K. The company's U.K. partners,... 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | All news |
| Best Cancer Care |